Four RFLPs of the human insulin receptor gene: PstI, KpnI, RsaI (2 RFLPs). 1988

N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
Howard Hughes Medical Institute, Philadelphia, PA 19104.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004262 DNA Restriction Enzymes Enzymes that are part of the restriction-modification systems. They catalyze the endonucleolytic cleavage of DNA sequences which lack the species-specific methylation pattern in the host cell's DNA. Cleavage yields random or specific double-stranded fragments with terminal 5'-phosphates. The function of restriction enzymes is to destroy any foreign DNA that invades the host cell. Most have been studied in bacterial systems, but a few have been found in eukaryotic organisms. They are also used as tools for the systematic dissection and mapping of chromosomes, in the determination of base sequences of DNAs, and have made it possible to splice and recombine genes from one organism into the genome of another. EC 3.21.1. Restriction Endonucleases,DNA Restriction Enzyme,Restriction Endonuclease,Endonuclease, Restriction,Endonucleases, Restriction,Enzymes, DNA Restriction,Restriction Enzyme, DNA,Restriction Enzymes, DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015252 Deoxyribonucleases, Type II Site-Specific Enzyme systems containing a single subunit and requiring only magnesium for endonucleolytic activity. The corresponding modification methylases are separate enzymes. The systems recognize specific short DNA sequences and cleave either within, or at a short specific distance from, the recognition sequence to give specific double-stranded fragments with terminal 5'-phosphates. Enzymes from different microorganisms with the same specificity are called isoschizomers. EC 3.1.21.4. DNA Restriction Enzymes, Type II,DNase, Site-Specific, Type II,Restriction Endonucleases, Type II,Type II Restriction Enzymes,DNase, Site Specific, Type II,Deoxyribonucleases, Type II, Site Specific,Deoxyribonucleases, Type II, Site-Specific,Site-Specific DNase, Type II,Type II Site Specific DNase,Type II Site Specific Deoxyribonucleases,Type II Site-Specific DNase,Type II Site-Specific Deoxyribonucleases,Deoxyribonucleases, Type II Site Specific,Site Specific DNase, Type II

Related Publications

N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
April 1991, Nucleic acids research,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
December 1990, Nucleic acids research,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
June 1998, Clinical genetics,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
August 1986, Nucleic acids research,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
April 1989, Nucleic acids research,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
June 1986, Nucleic acids research,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
January 2013, Asian Pacific journal of cancer prevention : APJCP,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
July 1989, Nucleic acids research,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
September 1988, Nucleic acids research,
N J Cox, and R S Spielman, and C R Kahn, and D Müller-Wieland, and K M Kriauciunas, and R Taub
October 1993, Human molecular genetics,
Copied contents to your clipboard!